MLICM
IMDZ

Metropolitan Life Insurance Company (MetLife)’s Immune Design Corp. IMDZ Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,824
Closed -$177K – 2609
2015
Q4 		$177K Buy
+8,824
New +$152K ﹤0.01% 2339
2015
Q3 		– Sell
-8,636
Closed -$178K – 2763
2015
Q2 		$178K Buy
+8,636
New +$204K ﹤0.01% 2475

Other funds holding IMDZ

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IMDZ Position: Q1 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Immune Design Corp. (IMDZ) in Q1 2016, closing a stake of 8,824 shares — an estimated $177K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IMDZ in Q2 2015 and held it in 2 quarters. The position peaked at $178K in Q2 2015. 59 funds tracked by Wall St. Rank hold IMDZ as of Q1 2016.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Immune Design Corp. position as of Q1 2016 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,824 Immune Design Corp. shares in Q1 2016, an estimated $177K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Immune Design Corp. in Q2 2015 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Immune Design Corp. position peaked at $178K in Q2 2015.
  • 59 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2016, filed 16 May 2016.